References
King WJ, Greene GL. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 1984;307:745–7.
Perrot-Applanat M, Logeat F, Groyer-Picard MT, Milgrom E. Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 1985;116:1473–84.
Welshons WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature 1984;307:747–9.
Guiochon-Mantel A, Loosfelt H, Lescop P, et al. Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 1989;57:1147–54.
Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M, Milgrom E. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J 1991;10:3851–9.
Madan AP, DeFranco DB. Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 1993;90:3588–92.
Dauvois S, White R, Parker MG. The antiestrogen ICI182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 1993;106:1377–88.
Perrot-Applanat M, Lescop P, Milgrom E. The cytoskeleton and the cellular traffic of the progesterone receptor. J Cell Biol 1992;119:337–38.
Mandell RB, Feldherr CM. Identification of two hsp70-relatedXenopus oocyte proteins that are capable of recycling across the nuclear envelope. J Cell Biol 1990;111:1775–83.
Guiochon-Mantel A, Delabre K, Lescop P, Milgrom E. Nuclear localization signals also mediate the outward movement of proteins from the nucleus, Proc Natl Acad Sci USA 1994;91:7179–83.
Klein-Hitpass L, Cato ACB, Henderson D, Ryffel GU. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res 1991 ;19:1227–34.
Delabre K, Guiochon-Mantel A, Milgrom E. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc Natl Acad Sci USA 1993;90:4421–5.
Guiochon-Mantel A, Loosfelt H, Ragot T, et al. Receptors bound to antiprogestin form abortive complexes with hormone responsive elements. Nature 1988;336:695–8.
Milgrom E, Luu Thi MT, Atger M, Baulieu EE. Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus. J Biol Chem 1973;248:6366–74.
Vu Hai MT, Logeat F, Warembourg M, Milgrom E. Hormonal control of progesterone receptors. Ann NY Acad Sci 1977;286:199–209.
Mester J, Baulieu EE. Progesterone receptors in the chicken oviduct. Eur J Biochem 1977;72:403–14.
Horwitz KB, McGuire WL. Oestrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978;253:2223–8.
Garcia E, Bouchard P, De Brux J, et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988;67:80–7.
Chalbos D, Vignon F, Keydar I, Rochefort H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab 1982;55:276–83.
Prud'homme JF, Fridlansky F, Le Cunff M, et al. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 1985;4:11–21.
Savouret JF, Bailly A, Misrahi M, et al. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J 1991;10:1875–83.
Berry M, Metzger D, Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 1990;9:2811–8.
Savouret JF, Rauch M, Redeuilh G, et al. Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J Biol Chem 1994;269:28955–62.
Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354–7.
Cavaillès V, Dauvois S, Danielian PS, Parker MG. Interaction of proteins with transcriptionally active estrogen receptor. Proc Natl Acad Sci USA 1994;91:10009–13.
Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 1996;15:3667–75.
Halachmi S, Marden E, Martin G, Mackay H, Abbondanza C, Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994, 264:1455–8
Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403–14.
Hörlein AJ, Näär AM, Heinzel T, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995;377:397–404.
Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995;377:454–7.
Cavaillès V, Dauvois S, L'Horset F, et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995;14:3741–51.
Le Douarin B, Zechel C, Gamier JM, et al. The N-terminal, part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995;14:2020–33.
vom Baur E, Zechel C, Heery D, et al. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGl and TIF1. EMBO J 1996;15:110–24.
Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995;374:91–4.
Guiochon-Mantel A, Savouret JF, Quignon F, Delabre K, Milgrom E, de Thé H. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol Endocrinol 1995;9:1791–803.
Imhof MO, McDonnell DP. Yeast RSP5 and its human homolog hRPFl potentiate hormone-dependent activation of transactivation by human progesterone and glucocorticoid receptors. Mol Cell Biol 1996;16:2594–605.
de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature 1990;347:558–61.
Muchardt C, Yaniv M. A human homologue ofSaccharomyces cerevisiae SNF2/SWI2 andDrosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 1993;12:4279–90.
Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3. Proteins for transcriptional enhancement by steroid receptors. Science 1992;258:1598–604.
Struhl K. Chromatin structure and RNA polymerase II connection: implications for transcription. Cell 1996;84:179–82.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Milgrom, E., Savouret, J.F., Mantel, A. et al. Promoter- and cell-specific responses to sex steroids. Osteoporosis Int 7 (Suppl 1), 23–28 (1997). https://doi.org/10.1007/BF01674809
Issue Date:
DOI: https://doi.org/10.1007/BF01674809